Effects of dolasetron injection: A Synthesis of Findings from 29 Studies
- Home
- Effects of dolasetron injection
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of dolasetron injection: A Synthesis of Findings from 29 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Dolasetron is a medication that has been shown to be effective in preventing postoperative nausea and vomiting (PONV), a common complication after surgery. 20 found that combining dolasetron with dexamethasone was more effective than dolasetron alone in reducing the incidence and severity of emetic symptoms and improving patient satisfaction. A study published in 6 demonstrated that dolasetron was a safe and effective preventive treatment for PONV in women undergoing outpatient laparoscopic gynecologic surgery. Several studies have also indicated that dolasetron is comparable or superior to other 5-HT3 receptor antagonists, such as ondansetron, in preventing PONV. 7 , 15 , 16 . Moreover, research suggests that dolasetron is effective in preventing nausea and vomiting caused by chemotherapy, particularly those involving cisplatin, and might be more beneficial than traditional antiemetics like metoclopramide. 8 , 5 . Further research is needed to assess dolasetron's potential in preventing radiation-induced nausea and vomiting. 12 .
Benefits and Risks
Benefit Summary
Dolasetron has been shown to effectively prevent nausea and vomiting after surgery, as well as those induced by chemotherapy and potentially radiation therapy. Several studies highlight its comparable or superior efficacy compared to other 5-HT3 receptor antagonists. Additionally, dolasetron has demonstrated effectiveness exceeding traditional antiemetics like metoclopramide.
Risk Summary
While generally considered safe, dolasetron may cause side effects such as headache, dizziness, and diarrhea. It is important to note that dolasetron can potentially affect the electrical activity of the heart, leading to a prolonged QT interval. This prolongation can increase the risk of irregular heartbeats. Individuals with heart problems or those taking medications for heart conditions should consult their physician before using dolasetron.
Comparison Between Studies
Commonalities Between Studies
These studies consistently show that dolasetron is effective in preventing postoperative nausea and vomiting. A common finding across many studies is that dolasetron is comparable or superior to other 5-HT3 receptor antagonists in terms of effectiveness.
Differences Between Studies
The studies vary in terms of dolasetron dosage, administration methods, patient populations, and outcome measures. This makes direct comparison of results challenging. For example, while 20 shows that combining dolasetron with dexamethasone is effective, 6 suggests that dolasetron alone is effective. The study in 29 focuses on comparing the pharmacokinetics of oral and intravenous dolasetron administration.
Consistency and Contradictions in Results
The studies demonstrate a consistent finding that dolasetron is effective in preventing postoperative nausea and vomiting. However, the optimal dosage and administration method remain unclear. Further research is needed to investigate potential interactions between dolasetron and other medications.
Considerations for Real-Life Application
While numerous studies support dolasetron's effectiveness in preventing postoperative nausea and vomiting, it is important to remember that dolasetron may pose higher risks to individuals with heart problems or those taking heart medications. Consulting a physician before using dolasetron is crucial.
Limitations of Current Research
Many studies on dolasetron are relatively small, necessitating larger-scale research. The long-term safety and efficacy of dolasetron remain unestablished. Further research is required to investigate potential interactions with other medications.
Future Research Directions
Future research should focus on identifying the optimal dosage and administration method for dolasetron. Long-term follow-up studies are necessary to assess long-term safety and efficacy. Pharmacodynamic studies are crucial to determine potential interactions with other medications.
Conclusion
Numerous studies have shown dolasetron's effectiveness in preventing postoperative nausea and vomiting. However, individuals with heart problems or those taking heart medications may experience higher risks when using dolasetron. Consulting a physician before using dolasetron is essential. Further research regarding dolasetron is necessary.
Benefit Keywords
Risk Keywords
Article Type
Author: BenedictC R, ArbogastR, MartinL, PattonL, MorrillB, HahneW
Language : English
Author: KrisM G, PendergrassK B, NavariR M, GroteT H, NelsonA M, ThomasV, FergusonB B, AllmanD S, PizzoB A, BakerT W, FernandoI J, ChernoffS B
Language : English
Author: SanchezL A, HoldsworthM, BartelS B
Language : English
Author: FrighettoL, LoewenP S, DolmanJ, MarraC A
Language : English
Author: ChevallierB, CappelaereP, SplinterT, FabbroM, WendlingJ L, CalsL, CatimelG, GiovanniniM, KhayatD, BastitP, ClaverieN
Language : English
Author: GraczykS G, McKenzieR, KallarS, HickokC B, MelsonT, MorrillB, HahneW F, BrownR A
Language : English
Author: KorttilaK, ClergueF, LeeserJ, FeissP, OlthoffD, Payeur-MichelC, WesselP, NaveS, HahneW, BrownR
Language : English
Author: YeildingA, BertoliL, EisenbergP, PleziaP, ModianoM R, AlbertsD S, KhojastehA, CramerM B, HahneW F
Language : English
Author: DiemunschP, D'HollanderA, PaxtonL, SchoefflerP, WesselP, NavéS, BrownR A, HahneW F
Language : English
Author: LermanJ, SimsC, SikichN, GowR, ChinC, DempseyE, HowardD R, KeungA C
Language : English
Author: SiddiquiM Asif A, ScottLesley J
Language : English
Author: BeyP, WilkinsonP M, ResbeutM, BourdinS, Le FlochO, HahneW, ClaverieN
Language : English
Author: HerndonAndrea K, QuimbyJessica M, SiebergLiberty G, DavisLeigh, CaressAmber L, LigasSabina, HansenRyan J, WittenburgLuke A, GustafsonDanial L
Language : English
Author: QuraishiSadeq A, SchulerGregg H, JanickiPiotr K
Language : English
Author: WalkerJ B
Language : English
Author: KovacA L, ScuderiP E, BoernerT F, ChellyJ E, GoldbergM E, HantlerC B, HahneW F, BrownR A
Language : English
Author: JantunenI T, KatajaV V, MuhonenT T, ParviainenT
Language : English
Author: StubbsK, MartinL A, DimmittD C, PreadyN, HahneW F
Language : English
Author: BenedictC R, ArbogastR, MartinL, PattonL, MorrillB, HahneW
Language : English
Author: PiperS N, TriemJ G, RöhmK D, KrankeP, MaleckW H, BoldtJ
Language : German
Author: PhilipB K, PearmanM H, KovacA L, ChellyJ E, WetchlerB V, McKenzieR, MonkT G, DershwitzM, MingusM, SungY F, HahneW F, BrownR A
Language : English
Author: HeskethP J, GandaraD R, HeskethA M, FacadaA, PerezE A, WebberL M, MartinL A, CramerM B, HahneW F
Language : English
Author: HuntT L, CramerM, ShahA, StewartW, BenedictC R, HahneW F
Language : English
Author: IatrouChristos A, DragoumanisChristos K, VogiatzakiTheodosia D, VretzakisGeorge I, SimopoulosConstantinos E, DimitriouVasilios K
Language : English
Author: EberhartL H, LindenthalM, SeelingW, GäckleH, GeorgieffM
Language : German
Author: DiemunschP, LeeserJ, FeissP, D'HollanderA, BradburnB G, PaxtonD, WhitmoreJ, PanouillotP, NavéS, BrownR A, HahneW F
Language : English
Author: PerezE A
Language : English
Author: BalfourJ A, GoaK L
Language : English
Author: KeungA C, LandriaultH, LefebvreM, GossardD, DempseyE E, JuneauM, DimmittD, CastlesM, RobertsL, SpenardJ
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.